General Information
Revision date
2016-03-06
Product name
IA2 Protein
Substance name
Refer to the instruction booklet for proper and intended
Product Synonyms
IA2
1.2.1 Relevant identified uses
Otherwise, contact supplier for specific applications
supplier name
MyBioSource, Inc
Emergency telephone
1.858.633.0165, 1.858.633.0166
Icons in SDS
Company Information
company name
MyBioSource, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
sales@mybiosource.com
Section 2
SECTION 2: Hazards identification
Directive 1999/45/EC: Physical state: Liquid. Odor: Odorless.
Principle Routes of Exposure
Dermal contact. Eye contact. Inhalation. Ingestion
Potential Acute Health Effects
Inhalation: No known significant effects or critical hazards. Ingestion: No known significant effects or critical hazards. Skin: No known significant effects or critical hazards. Eyes: No known significant effects or critical hazards.
Potential chronic health
effects Carcinogenicity: No known significant effects or critical hazards. Mutagenicity: No known significant effects or critical hazards. No known significant effects or critical hazards
Teratogenic Effects
No known significant effects or critical hazards Developmental effects: No known significant effects or critical hazards. Fertility effects: No known significant effects or critical hazards. Over-exposure signs/symptoms Ingestion: No specific data. Inhalation: No specific data. Skin: No specific data. Eyes: No specific data.
Medical Conditions Generally Aggravated by Exposure
None known The preparation is not classified as dangerous according to Directive 1999/45/EC and its amendments. Not classified See toxicological information (section 11)
